Temozolomide News and Research

RSS
Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Use of tumor-treating fields along with chemotherapy improves survival in patients with brain tumor

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

Scientists identify way to sensitize drug-resistant glioblastoma cells to chemotherapy

TGen: PPF drug could help treat patients with deadly brain cancer

TGen: PPF drug could help treat patients with deadly brain cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

FDA approves expanded indication for Optune device for brain cancer patients

FDA approves expanded indication for Optune device for brain cancer patients

Genetics and race influence patients' response to anticancer drug treatments

Genetics and race influence patients' response to anticancer drug treatments

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

DelMar presents updated VAL-083 Phase I/II trial data at GBM2015 meeting

Innovative vaccine therapy shows promise against glioblastoma brain tumors

Innovative vaccine therapy shows promise against glioblastoma brain tumors

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

Structural brain changes found in chemoradiation-treated glioblastoma patients

Structural brain changes found in chemoradiation-treated glioblastoma patients

New technique improves survival time for glioblastoma patients by 50%

New technique improves survival time for glioblastoma patients by 50%

New study suggests that IDH1 gene may be prognostic marker for anaplastic astrocytoma

New study suggests that IDH1 gene may be prognostic marker for anaplastic astrocytoma

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies

ASCO 2015: UH Seidman Cancer Center researchers present data from several new studies

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

Additional preclinical data on DelMar’s VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting

DelMar to present new data on development of VAL-083 at 2015 ASCO Annual Meeting

Study suggests possibility of developing personalized treatments for brain cancer

Study suggests possibility of developing personalized treatments for brain cancer

Experimental drug that attacks brain tumor cells passes early tests

Experimental drug that attacks brain tumor cells passes early tests

Chemotherapy, radiation therapy combination improves outcomes for people with low-grade brain cancer

Chemotherapy, radiation therapy combination improves outcomes for people with low-grade brain cancer

Novogen's TRXE-009 therapy shows promise against brain cancer

Novogen's TRXE-009 therapy shows promise against brain cancer